+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "H2 Receptor Antagonists"

From
From
Antiulcerant Drugs: Global Markets to 2022 - Product Thumbnail Image

Antiulcerant Drugs: Global Markets to 2022

  • Report
  • May 2018
  • 185 Pages
  • Global
From
From
From
Research Report on China's Roxatidine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Roxatidine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Global GERD Market 2023-2027 - Product Thumbnail Image

Global GERD Market 2023-2027

  • Report
  • December 2022
  • 166 Pages
  • Global
From
Anti Peptic Ulcer Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Anti Peptic Ulcer Drugs Industry Forecasts - China Focus

  • Report
  • February 2024
  • 107 Pages
  • China
From
Anti Peptic Ulcer Drugs Companies in China - Product Thumbnail Image

Anti Peptic Ulcer Drugs Companies in China

  • Report
  • February 2024
  • 54 Pages
  • China
From
Anti Peptic Ulcer Drugs Markets in China - Product Thumbnail Image

Anti Peptic Ulcer Drugs Markets in China

  • Report
  • February 2024
  • 211 Pages
  • China
From
From
Loading Indicator

H2 Receptor Antagonists are a type of drug used to treat gastrointestinal disorders. They work by blocking the action of histamine, a chemical that stimulates the production of stomach acid. This helps to reduce the amount of acid in the stomach, which can help to relieve symptoms of acid reflux, heartburn, and other gastrointestinal issues. H2 Receptor Antagonists are available in both prescription and over-the-counter forms. Commonly prescribed H2 Receptor Antagonists include cimetidine, ranitidine, and famotidine. H2 Receptor Antagonists are widely used to treat a variety of gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. They are also used to prevent and treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Some companies that produce H2 Receptor Antagonists include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Show Less Read more